Cargando…
Potential Morbidity Reduction for Lung Stereotactic Body Radiation Therapy Using Respiratory Gating
SIMPLE SUMMARY: Lung stereotactic body radiotherapy (SBRT) is the standard of care for early-stage lung cancer and oligometastases. For SBRT, motion has to be considered to avoid misdosage. Respiratory phase gating, meaning to irradiate the target volume only in a predefined gating motion phase wind...
Autores principales: | Kraus, Kim Melanie, Simonetto, Cristoforo, Kundrát, Pavel, Waitz, Vanessa, Borm, Kai Joachim, Combs, Stephanie Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533802/ https://www.ncbi.nlm.nih.gov/pubmed/34680240 http://dx.doi.org/10.3390/cancers13205092 |
Ejemplares similares
-
Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020) -
Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation
por: Kraus, Kim Melanie, et al.
Publicado: (2022) -
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
por: Kraus, K. M., et al.
Publicado: (2021) -
Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023) -
Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations
por: Herman, Tania De La Fuente, et al.
Publicado: (2010)